RRM2 and breast carcinoma: High levels of NEAT1, miR-21, and RRM2 have been observed in different breast cancer cell lines, and their elevated levels correlate with poor clinical outcomes, suggesting that the NEAT1/miR-21-RRM2 signaling axis contributes to breast cancer development (54).